2022
DOI: 10.1002/slct.202203757
|View full text |Cite
|
Sign up to set email alerts
|

Hybrid Pyrazole‐Tetrazole Derivatives with High α‐Amylase Inhibition Activity: Synthesis, Biological Evaluation and Docking Study

Abstract: The elaboration of some N‐alkylated pyrazole‐tetrazole derivatives is reported. The structures of the newly ones are verified using NMR and FTIR spectroscopies, mass spectrometry as well as elemental analysis. Their potencies to inhibit the α‐amylase enzyme were evaluated using spectrophotometric method and the obtained results showed that some of them were extremely potent with respect to the used positive control. The structure activity relationship showed that the α‐amylase inhibition activity depends on th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…Pyrazole- N -acetyl pyrazole-benzofuran derivative A demonstrated powerful antibacterial activity toward Escherichia coli and also a drug-likeness model score (DLS) equal to 0.83 ( Elsherif et al, 2020 ). Pyrazole-tetrazole derivative B (IC 50 = 3.45 × 10 −5 mg/ml) acts as an anti-diabetic agent, inhibiting the α-amylase enzyme more than acarbose (IC 50 = 0.26 mg/ml) nearly 10,000 times ( Harit et al, 2022 ). Coumarin-pyrazole derivative C displays high inhibitory activity as an anti-Alzheimer's agent toward acetylcholinesterase (AChE) (IC 50 = 4.41 ± 0.53 µg/ml), comparable to galanthamine (IC 50 = 6.27 ± 1.15 µg/ml) ( Benazzouz-Touami, et al, 2022 ) ( Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Pyrazole- N -acetyl pyrazole-benzofuran derivative A demonstrated powerful antibacterial activity toward Escherichia coli and also a drug-likeness model score (DLS) equal to 0.83 ( Elsherif et al, 2020 ). Pyrazole-tetrazole derivative B (IC 50 = 3.45 × 10 −5 mg/ml) acts as an anti-diabetic agent, inhibiting the α-amylase enzyme more than acarbose (IC 50 = 0.26 mg/ml) nearly 10,000 times ( Harit et al, 2022 ). Coumarin-pyrazole derivative C displays high inhibitory activity as an anti-Alzheimer's agent toward acetylcholinesterase (AChE) (IC 50 = 4.41 ± 0.53 µg/ml), comparable to galanthamine (IC 50 = 6.27 ± 1.15 µg/ml) ( Benazzouz-Touami, et al, 2022 ) ( Fig.…”
Section: Introductionmentioning
confidence: 99%
“…10 Similarly, tetrazole derivatives incorporated with a diverse range of other structural motifs have exhibited various biological characteristics including CNS stimulant, analgesic, antibacterial, anticancer, antifungal, anticonvulsant, antiinflammatory, antidiabetic, antiproliferative, antitubercular, antimalarial, antidepressant, and anticardiovascular properties. [11][12][13][14][15][16][17][18][19][20][21] Tetrazole is a five-membered heteroaromatic motif that is acidic in nature (pK a is akin to carboxylic acid) and ionizes at physiological pH. 22 As is known, the tetrazole moiety possesses four nitrogens that can serve as both bifurcated (multicenter) and linear hydrogen bond donors as well as acceptors.…”
Section: Introductionmentioning
confidence: 99%